At the end of the Second World
War, the United States government took, among other concessions, the patents
and the inventors of Germany to build its chemical, infrastructure, and
technological industries that had been bested by the Third Reich. From dyes to magnetic tape to rockets, the
German reparations catalyzed a period of transformational growth that built the
likes of Silicon Valley and metropolitan Boston and Federal labs and Beltway Bandits
that speckle the I-95, I-66 and I-64 corridors.
I’ve been deeply saddened in my
experience in Australia where I’ve seen hundreds of millions of dollars poured
into “research” and “innovation” which is universally redundant to technologies
and initiatives the world over. One of
the most tragic comedies is the frequently lauded claim of Australia’s
invention of WiFi. Sad that CSIRO and
the Australian government don’t take the time to read their own patent which
states that, “…wireless LANs are known, however, hitherto they have been
substantially restricted to low data transmission rates. One wireless LAN which is commercially
available is that sold by Motorola under the trade name ALTAIR.” Australia didn’t invent WiFi, they improved
upon the inventions of many others. But
that’s not the story that governments want to tell taxpayers. Both at the State and Commonwealth level, now
billions of dollars are committed to a pretense of innovation for economic
development which assumes that somehow basic research will be the country’s
answer to decreased commodity exports. And
rather than doing what they’ve done occasionally quite well – adapting
innovations for more applicable and relevant deployment – the monotonous
drumbeat of “invention” and “innovation” clamor on.
It was particularly interesting
this morning when I read the U.S. Supreme Court’s decision on the Samsung damages
award sought by Apple. In an unanimous
decision, the Court overturned the $399 million jury verdict against Samsung
for alleged infringement of Apple’s patents.
The patents in question were on “inventions” like a rectangle with
rounded edges, an interactive screen that responds to finger movements and
other life-changing smartphone features allegedly “invented” by the
companies. Ironically, the Court
stipulated that neither Apple nor Samsung had adequately defined what the “relevant
article of manufacture” was that was the basis for the alleged damage.
With over 88 million patents
worldwide to date and with that number growing by close to a million
disclosures globally each year, we’ve lost the plot. We wouldn’t know an invention if it bit us in
the face. Public dollars are being
thrown at academia and industry each year to come up with solutions which are
already out there to be deployed or repurposed.
Now there will be those who say, “But
Dave, that’s just your opinion. I’ve
paid a patent attorney a lot of money to protect my invention and they’ve said
I can get a patent.” Yes, and a
lap-dancer in a night club will tell you that she loves you for the right
price. Saying so doesn’t make it true.
There’s another way to go. When Elinor Ostrom won the Nobel Prize for
her work on the Commons in 2009, she could not have imagined the import of her
work far beyond the notion of public goods and public rights. Ever since the 18th century,
patent disclosures have secured for their applicants certain market rights and
restrictions. But, the public – who was
supposed to benefit from the advance of the Arts and Sciences – has gotten more
expensive products and has subsidized industry and higher education
unwittingly. However, now with over 92%
of the world’s intellectual property unprotected in most of the world
(patents have to be filed in the countries where inventors want market
protections, otherwise no market right is enforceable in the others), the
ability for countries to research, integrate and commercialize the expensive IP
of others is at hand and most of the world is still not using
this innovation commons. That’s
right, what happened in the generic drug industry in the mid-20th
century is now possible with every industry.
And, for the current industrial
titans rife with their stockpiles of faux invention, another opportunity has
been created. Patents serve as an
indicator of corporate intent. Maybe
where you’re planning to go. Maybe where
you know you’re going to hit competition.
No matter what the rationale, these documents are a signal of market
intent and that very signal drives our equity funds and our recently launched
CNBC IQ100 Index powered by M·CAM. In the last quarter of 2016, our Innovation
Index has outperformed the S&P and NASDAQ by as much as 300%! Ironically, some of our best trading data
comes from seeing the fallacious claims of Apple and Samsung months and years
ahead of time and investing accordingly.
It’s time to end the illusion of “creation”
once and for all. We don’t make things ex nihilo. We’re trained and enculturated to adapt
things for new contexts or efficiencies.
And as a result, it’s time that the public investment shifts from “invention”
illusions to Applied Innovation. This
transition has already transformed the pharmaceutical industry and is now
poised to change the face of business around the world. President-elect Trump’s recent pronouncements
regarding the termination of TPP has just accelerated that transformation and
it’s time for the world to ride the wave of innovation literacy. The Supreme Court just confirmed that that’s
a good idea (does that make it true????
Nah!)
x
I love ya Dave! Just knowing somebody out there is writing this keeps me going! Thanks for being you!!! Really
ReplyDeleteLaura
All the best for the holidays Dave
ReplyDelete